Abstract
A Phase 2 Trial of Midtreatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have